Clinical observation of high-flow nasal cannula with non-rebreather mask use on severe or critically ill COVID-19 diabetic patients

AFM Tareq Bhuiyan; Sudipta Deb Nath; Md Jakir Hossain; Shuva Das; Moumita Das; Moinul Ahsan; Md. Iftekher-E-Alam Ziad; Fahmida Khatun Padma; Rana Dey; AKM Shamsul Alam; Farial Hoque Zehan; Ayan Saha

doi:10.1101/2021.10.13.21264946

Abstract

Background and aims Prevalence of diabetes is a vital factor in COVID-19’s clinical prognosis. This study aimed to investigate and compare the efficacy of High-flow Nasal Cannula (HFNC) with/without non-rebreather mask (NRM) use on critical COVID-19 patients with/without diabetes.

Methods For analysis and comparison, epidemiological, biochemical, and clinical data were collected from 240 HFNC (±NRM) treated severe and critical COVID-19 patients (diabetic = 136; non-diabetic = 104) admitted into ICUs of five hospitals in Chattogram, Bangladesh.

Results 59.1% of patients with fever had diabetes (p=0.012). ICU stay was longer for diabetic patients (9.06±5.70) than non-diabetic patients (7.41±5.11) (p=0.020). Majority of the hypertensive patients were diabetic (68.3%; p<0.001). Majority of diabetic patients (70.4%; p<0.005) had elevated creatinine levels. Partial pressure of oxygen (mmHg) after HFNC (only) administration was significantly (p=0.031) higher in non-diabetic patients (69.30±23.56) than in diabetic patients (61.50±14.49). Diabetic (62.64±13.05) and non-diabetic patients (59.40±13.22) had almost similar partial pressure of oxygen (mmHg) from HFNC with NRM. Patients with elevated RBS required NRM with HFNC five times (AOR=5.1, 1.2-20.8) higher than others. Besides age, and hypertension were significantly associated with the HFNC+NRM treated diabetic patients. Factors those affected the HFNC only treated patients were fever and impaired glucose tolerance.

Conclusions The results of this study imply that oxygen supply with HFNC and NRM may be beneficial for the elderly/hypertensive diabetic patients with COVID-19 associated AHRF; and that increased blood glucose level could be a determinant for the need of HFNC + NRM treatment.

Highlights

Elderly diabetic patients required both HFNC and NRM to increase oxygen saturation.
Hypertension may be a factor for diabetic patients with COVID-19 requiring HFNC and NRM together.
‘HFNC + NRM’-combination therapy might be needed when blood glucose levels rise.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

This study did not receive any funding

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

This research and its protocol were approved by the 250 Bedded Chattogram General Hospital's Institutional Review Board (Approval No.: 1724)

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

E-mail: tbhuiyan83{at}gmail.com
E-mail: sudipto.sb45{at}gmail.com
E-mail: jakir.hossain{at}unsw.edu.au
E-mail: shuvadas47cmchgeb{at}gmail.com
E-mail: moumita.das.2822{at}gmail.com
E-mail: dr.moinul78{at}gmail.com
E-mail: iftekherziad{at}gmail.com
E-mail: padmafahmida4{at}gmail.com
E-mail: ranaprata415{at}gmail.com
E-mail: alamakms{at}yahoo.com
E-mail: fhzehan{at}gmail.com
One of the authors has been changed. Some changes in the Abstract, Results, Discussion, and Conclusion. Figure 1 is changed to Supplementary Figure 1. Figure 2 is changed to Figure 1. Table 1 & 2 is merged.